{
  "docId": "019de070-c935-736b-bfac-0e59550f8f0f",
  "docSlug": "bbdd6d1004c11d68b286eff6aee60dc0",
  "documentTitle": "argenx SE | Results Presentation Deck | 20 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 20,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses a series of four big-number metrics to communicate clinical efficacy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-c935-736b-bfac-0e59550f8f0f/6",
  "deckHref": "/decks/019de070-c935-736b-bfac-0e59550f8f0f",
  "deckJsonHref": "/decks/019de070-c935-736b-bfac-0e59550f8f0f.json",
  "deckAnchorHref": "/decks/019de070-c935-736b-bfac-0e59550f8f0f#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.18,
        "x": 0.52,
        "y": 0.02
      },
      "kind": "metric",
      "text": "60% Deep Responses",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2279031d-0ca3-49fc-8541-841d457eee82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.18,
        "x": 0.08,
        "y": 0.02
      },
      "kind": "metric",
      "text": "78% Response Rate",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ccc8f4d-16ab-40f8-89b0-f548839b6e4a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.18,
        "x": 0.3,
        "y": 0.02
      },
      "kind": "metric",
      "text": "84% Fast Onset of Action",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9090be3a-9530-4168-93c9-a28aa734c818",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.18,
        "x": 0.74,
        "y": 0.02
      },
      "kind": "metric",
      "text": "OVER 50% Supportive of Individualized Dosing",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f361aa4c-21a1-4cff-87f6-0248aafef2ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.02,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Primary endpoint: MG-ADL responder ≥2-point improvement for at least four consecutive weeks during the first cycle* First secondary endpoint: QMG responder ≥3-point improvement for at least four consecutive weeks during the first cycle*",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d4a460b-825f-4fcb-b6d5-4e2004427f8e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.18,
        "x": 0.51,
        "y": 0.75
      },
      "kind": "subtitle",
      "text": "MG-ADL responders achieved minimal symptom expression (MG-ADL of 0 or 1)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "100b842f-d7c5-497b-8baf-31e9c13d13cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.18,
        "x": 0.74,
        "y": 0.75
      },
      "kind": "subtitle",
      "text": "Patients likely to benefit from individualized dosing",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2678e0c4-b0a1-446a-ad0a-319eded5b25e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.18,
        "x": 0.05,
        "y": 0.75
      },
      "kind": "subtitle",
      "text": "MG-ADL responders during first two cycles",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "871dd6e2-9c30-4e10-b21c-915c47c2f88b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.18,
        "x": 0.28,
        "y": 0.75
      },
      "kind": "subtitle",
      "text": "MG-ADL responders within first two weeks of treatment",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e681c239-94d1-45c7-bc8a-3457e888d18d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "Promising Value Proposition to MG Patients",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "60a4d299-1e51-4e61-a545-f2437dff7170",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Storytelling: audience calibration",
      "slug": "audience",
      "agent": "storyteller",
      "layer": "slide",
      "matchId": "346a3984-ffba-488e-af68-21dcf959da96",
      "evidence": "Patients on drug for more than 2 years",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 4,
      "beatId": "370e7a7b-342c-4314-a537-20aca17005f0",
      "arcName": "Rags to Riches",
      "arcSlug": "rags-to-riches",
      "beatName": "Rising Success",
      "beatSlug": "rags-to-riches-rising-success",
      "evidence": "The presentation highlights the company's promising pipeline and clinical trials",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}